Filing a lawsuit over defective surgical mesh does not actually involve filing a traditional class action. Surgical mesh cases are handled through multidistrict litigations, or MDLs, where individual lawsuits are consolidated for pretrial proceedings but each plaintiff keeps their own separate claim and potential payout. To get started, you need to document your complications, gather your surgical and medical records, and consult with a mass tort attorney who can file a short-form complaint tying your case into the appropriate MDL. There are currently 26,234 hernia mesh lawsuits pending across four federal MDLs, and the litigation is very much active heading into 2026. The distinction between an MDL and a class action matters because it directly affects how much compensation you can receive.
In a class action, everyone gets the same settlement. In an MDL, your payout depends on the severity of your individual injuries. Hernia mesh settlements have averaged between $60,000 and $100,000, with severe cases reaching well into six figures. One Hawaii man was awarded $4.8 million after needing revision surgery following a Bard Ventralex mesh implantation.
Table of Contents
- How Do You Actually File a Surgical Mesh Lawsuit?
- Which Manufacturers Are Being Sued and Where Do the Cases Stand?
- What Happened With Transvaginal Mesh Lawsuits?
- How Much Can You Expect From a Hernia Mesh Settlement?
- Statute of Limitations — When Is It Too Late to File?
- What Role Has the FDA Played in Surgical Mesh Issues?
- What to Watch for in 2026 and Beyond
- Frequently Asked Questions
How Do You Actually File a Surgical Mesh Lawsuit?
The process begins with a thorough review of your medical history. You need to confirm the date of your surgery, identify the specific mesh product and manufacturer, and document every complication you have experienced since implantation. Common qualifying complications include chronic pain, infection, mesh migration, adhesion formation, bowel obstruction, organ perforation, and hernia recurrence. You do not need to wait for an FDA recall to file suit. A formal recall is not required, and in fact, no new hernia mesh recalls have occurred in 2024 or 2025. Next, you need to gather your medical records.
This includes the original surgical report, hospital discharge summaries, notes from follow-up appointments, imaging results showing mesh complications, and records of any revision surgeries. These documents form the backbone of your claim and will determine how your case is valued. Once you have this documentation, a mass tort attorney will typically file a short-form complaint that references the master complaint already established in the relevant MDL. Most attorneys handling these cases work on contingency, meaning you pay nothing upfront and they take a percentage only if you receive compensation. One important comparison: filing as an individual within an MDL gives you far more control than a traditional class action would. You can negotiate your own settlement based on your specific injuries, reject a proposed settlement if you find it inadequate, and even proceed to your own trial if necessary. In a class action, you would be bound by whatever deal the class representatives negotiate on behalf of everyone.
Which Manufacturers Are Being Sued and Where Do the Cases Stand?
The four active hernia mesh MDLs target different manufacturers, and each is at a different stage of resolution. The largest by far involves Davol and its parent company C.R. Bard, with 23,728 pending cases. Covidien, a subsidiary of Medtronic, faces 2,260 cases. Atrium has 246 cases remaining. Both Bard and Atrium have entered global settlement agreements that are currently being processed, which means individual claimants in those MDLs may receive settlement offers in the coming months. However, if your mesh was manufactured by Covidien, the path forward looks different. Covidien has not agreed to a global settlement, and the litigation is heading to trial.
The first Covidien bellwether trial, Patterson v. Covidien, had jury selection set for February 17, 2026, with a pretrial conference in Boston on February 4. A second bellwether involving a Mississippi woman’s Covidien Symbotex patch is scheduled for July 2026. Bellwether trials serve as test cases that help both sides gauge how juries will respond to the evidence, and their outcomes often drive settlement negotiations. The key manufacturers across all surgical mesh litigation include C.R. Bard/Davol, Covidien (Medtronic), Ethicon (a Johnson & Johnson subsidiary), Atrium, Boston Scientific, and Coloplast. If you are unsure which manufacturer made your mesh, your surgical report should identify the specific product. Your attorney can then determine which MDL your case belongs in, or whether a state court filing makes more sense given your circumstances.
What Happened With Transvaginal Mesh Lawsuits?
The transvaginal mesh litigation provides a useful reference point for hernia mesh claimants wondering what resolution might look like. All seven transvaginal mesh MDLs have now closed as of February 2026, with more than 67,000 cases either settled or reaching verdicts. Manufacturers paid out an estimated $8 billion in total settlements across these cases. The scale of that payout reflects both the volume of cases and the severity of injuries, which included chronic pelvic pain, mesh erosion through vaginal tissue, infections, and the need for painful removal surgeries. Settlement amounts in the transvaginal mesh litigation ran significantly higher than current hernia mesh averages. Estimated payouts ranged from $150,000 to over $400,000 depending on case severity.
As recently as May 2025, a federal court in Miami ordered Boston Scientific to pay $26.7 million to four women over its Pinnacle pelvic floor replacement kit. That works out to an average of nearly $6.7 million per plaintiff, though individual awards within that verdict likely varied based on each woman’s injuries. For hernia mesh plaintiffs, the transvaginal mesh precedent is both encouraging and sobering. It shows that manufacturers will eventually pay, but the process took years. Many transvaginal mesh cases were filed in 2012 and 2013, meaning some plaintiffs waited over a decade for compensation. Hernia mesh litigation is on a similar timeline, with many cases filed in 2017 and 2018 still awaiting resolution.
How Much Can You Expect From a Hernia Mesh Settlement?
Hernia mesh settlement amounts depend heavily on individual circumstances. The current average range sits between $60,000 and $100,000, but that number obscures significant variation. Cases involving a single revision surgery with a good outcome will land on the lower end or below the average. Cases involving multiple revision surgeries, chronic pain requiring ongoing treatment, bowel resection, or permanent disability push well above the average and into six-figure territory. The tradeoff every plaintiff faces is between settling and going to trial.
Accepting a settlement offer provides certainty and faster payment, but the amount may be less than what a jury would award. Going to trial offers the chance at a much larger verdict, as demonstrated by the $4.8 million award in the Bard Ventralex case, but it also carries the risk of losing entirely and receiving nothing. Most mass tort attorneys will advise you based on the strength of your medical evidence, the specific manufacturer involved, and what bellwether verdicts suggest about jury attitudes. It is also worth noting that the Bard and Atrium global settlements currently being processed will establish specific tiers based on injury severity. If you are part of one of these MDLs, your attorney should be able to explain where your case falls within the settlement matrix and what range of compensation to expect. Claimants who reject their settlement offers may retain the right to pursue individual litigation, though this varies by the terms of each settlement agreement.
Statute of Limitations — When Is It Too Late to File?
Most states impose a two to three year statute of limitations on product liability claims, but the timeline for surgical mesh cases is not as straightforward as counting from your surgery date. The discovery rule, recognized in most jurisdictions, starts the clock from the date you knew or should have known that the mesh caused your injury, not from the date of implantation. This distinction is critical because many mesh complications develop gradually over months or years, and patients often do not connect their symptoms to the mesh until a doctor identifies it as the source. However, the discovery rule is not a blank check. If you were told by a physician in 2022 that your mesh had migrated and was causing your pain, your statute of limitations likely started running in 2022 regardless of when the mesh was originally implanted.
Courts will look at when you had enough information to reasonably suspect the mesh was the problem. Waiting too long after that point, even if you had not yet consulted an attorney, can bar your claim entirely. There is an additional wrinkle for cases involving manufacturers that have entered global settlements. These agreements sometimes include their own filing deadlines that differ from state statutes of limitations. If Bard or Atrium has set a claims deadline as part of their settlement, missing that deadline could mean losing your right to participate even if your state’s statute of limitations has not technically expired. This is one of the strongest reasons to consult with an attorney sooner rather than later.
What Role Has the FDA Played in Surgical Mesh Issues?
The FDA’s handling of surgical mesh has been a significant part of the broader story, though it has not resulted in the kind of sweeping recalls plaintiffs might expect. No new hernia mesh recalls occurred in 2024 or 2025. The most notable prior recall involved Ethicon’s Proceed Surgical Mesh, where over 18,000 units produced between 2005 and 2014 were recalled under a Class 2 classification due to packaging defects that caused delamination, meaning layers of the mesh could separate.
For plaintiffs, the absence of a recall does not weaken a lawsuit. Courts have consistently held that a product can be defective and cause compensable harm without the FDA having issued a recall. Attorneys building mesh cases rely on medical evidence of complications, expert testimony about design defects, and internal company documents rather than FDA enforcement actions.
What to Watch for in 2026 and Beyond
The Covidien bellwether trials scheduled for 2026 are the most significant upcoming events in hernia mesh litigation. Because Covidien has not entered a global settlement, the outcomes of these trials will likely determine whether Medtronic comes to the negotiating table or continues to fight cases individually. A plaintiff verdict in the Patterson case or the July trial could create enormous pressure to settle the remaining 2,260 Covidien cases.
A defense verdict could delay resolution for years. Meanwhile, the Bard and Atrium global settlements will continue processing throughout 2026, and claimants in those MDLs should expect to receive specific settlement offers if they have not already. For anyone still experiencing mesh complications who has not yet filed, the combination of active litigation, pending settlements, and discovery rule protections means the window remains open, but it will not stay open indefinitely.
Frequently Asked Questions
Do I need an FDA recall to file a surgical mesh lawsuit?
No. A formal FDA recall is not required to file a mesh lawsuit. Courts evaluate whether the product was defective based on medical evidence and expert testimony, not FDA enforcement actions. No new hernia mesh recalls have occurred in 2024 or 2025, yet tens of thousands of cases remain active.
What is the difference between an MDL and a class action for mesh lawsuits?
In an MDL, individual cases are grouped together for pretrial proceedings like discovery and motions, but each plaintiff retains their own claim and receives compensation based on their specific injuries. In a class action, all members are bound by the same outcome. Surgical mesh cases are handled as MDLs, which allows for individualized settlements.
How much are hernia mesh settlements worth?
Average hernia mesh settlements currently range between $60,000 and $100,000, though severe cases involving multiple surgeries or permanent complications can reach well into six figures. One notable case resulted in a $4.8 million verdict for a plaintiff who required revision surgery after Bard Ventralex mesh implantation.
Has the statute of limitations expired for surgical mesh lawsuits?
Not necessarily. Most states apply a discovery rule that starts the two to three year limitations period from when you knew or should have known the mesh caused your injury, rather than from the date of surgery. This can extend filing deadlines significantly for patients whose complications developed gradually.
Which mesh manufacturers have settled and which are still fighting?
C.R. Bard/Davol and Atrium have entered global settlement agreements that are currently being processed. Covidien, a Medtronic subsidiary, has not agreed to a global settlement and is proceeding to bellwether trials in 2026. All seven transvaginal mesh MDLs have closed, with manufacturers paying an estimated $8 billion total.
You Might Also Like
- What Happens If Not Enough People File Claims in a Class Action
- How to Find Class Action Lawsuits for Defective Medical Implants
- How to File a Class Action Lawsuit Against a Hospital for Malpractice